ME
Maria Emilia Dias Menezes
About Maria Emilia Dias Menezes
Data last updated:
Maria Emilia Dias Menezes is a Director at Wallace Pharmaceuticals Private Limited (since 1997), Managing Director at Indi Pharma Private Limited (since 2005) and Designated Partner at Wallace Medipharma Llp (since 2020), and holds 1 more current directorship. The companies operate in Pharma, Research & Development and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹700 Cr; the largest is Wallace Pharmaceuticals Private Limited at ₹673 Cr (FY 2025). Earlier, Maria Emilia Dias Menezes was a Director at Goodwin Biotechnology India Private Limited (2015–2017) and Director at Wallace Medipharma Private Limited (1998–2020) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wallace Pharmaceuticals Private Limited U24239GA1968PTC000080 | Director | 09 Dec 1997 | 1968 | ₹673 Cr (FY 2025) | Active |
 Indi Pharma Private Limited U24232GA1984PTC000556 | Managing Director | 15 Jun 2005 | 1984 | ₹26.28 Cr (FY 2024) | Active |
 Wallace Medipharma Llp AAS-0492 | Designated Partner | 26 Feb 2020 | 2020 | ₹19.2 Lakh (FY 2024) | Active |
| Wallace Medinova Llp AAR-9667 | Designated Partner | 18 Feb 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Goodwin Biotechnology India Private Limited U73100GA2006PTC004842 | Director | 31 Dec 2015 | 2006 | ₹45.5 Lakh (FY 2019) | Strike Off |
| Wallace Medipharma Private Limited U24232GA1998PTC002526 | Director | 19 Feb 1998 | 1998 | ₹1.5 Lakh (FY 2019) | Converted To Llp |
| Wallace Medinova Private Limited U52311GA1997PTC002273 | Director | 05 Feb 1997 | 1997 | ₹91,220 (FY 2019) | Converted To Llp |
| Shunyata Arts Private Limited U74950GA2001PTC002962 | Director | 14 Mar 2001 | 2001 | ₹1.6 Lakh (FY 2024) | Strike Off |
| Wallace Estates Private Limited U70200GA1996PTC002078 | Director | 30 Dec 1996 | 1996 | ₹28,886 (FY 2019) | Converted To Llp |
| Wallace Estates Llp AAR-7944 | Designated Partner | 03 Feb 2020 | 2020 | Strike Off | |
| Wallace Laboratories Private Limited U33112GA1996PTC002077 | Director | 15 Mar 2006 | 1996 | ₹22.71 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Maria Emilia Dias Menezes
| Name | DIN | Company | Designation |
|---|---|---|---|
| Cesar Mauricio Jose De Menezes | 00407272 | Wallace Pharmaceuticals Private Limited , Indi Pharma Private Limited and 2 more | Managing Director |
| Pankaj Kumar | 08761171 | Wallace Pharmaceuticals Private Limited | Director |
| Rajashekhar Rayanagoudar Basanagouda | 07525704 | Wallace Pharmaceuticals Private Limited | Whole-Time Director |
| Rashmi Menezes | 01006018 | Wallace Pharmaceuticals Private Limited | Managing Director |
| Sandeep Inamdar | 10935367 | Wallace Pharmaceuticals Private Limited | Whole-Time Director |
| Vinay Pinto | 01005975 | Wallace Pharmaceuticals Private Limited | Director |
| Antonio Xavier Paulo Fernandes | 00407426 | Indi Pharma Private Limited | Director |
| Ramakrishna Vasudev Bhat | 08581846 | Indi Pharma Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maria Emilia Dias Menezes
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maria Emilia Dias Menezes
Maria Emilia Dias Menezes currently holds 4 directorships: Wallace Pharmaceuticals Private Limited (Director, since 09 Dec 1997, revenue ₹673 Cr (FY 2025)); Indi Pharma Private Limited (Managing Director, since 15 Jun 2005, revenue ₹26.28 Cr (FY 2024)); Wallace Medipharma Llp (Designated Partner, since 26 Feb 2020, revenue ₹19.2 Lakh (FY 2024)); Wallace Medinova Llp (Designated Partner, since 18 Feb 2020).
Maria Emilia Dias Menezes was first appointed on 30 Dec 1996 as Director at Wallace Estates Private Limited. The most recent appointment on record is 26 Feb 2020 at Wallace Medipharma Llp.
The 3 current companies of Maria Emilia Dias Menezes that report revenue have a combined latest revenue of ₹700 Cr: Wallace Pharmaceuticals Private Limited ₹673 Cr (FY 2025); Indi Pharma Private Limited ₹26.28 Cr (FY 2024); Wallace Medipharma Llp ₹19.2 Lakh (FY 2024).
Maria Emilia Dias Menezes held 7 earlier board appointments: Goodwin Biotechnology India Private Limited (Director, 31 Dec 2015 to 25 Jan 2017); Wallace Medipharma Private Limited (Director, 19 Feb 1998 to 25 Feb 2020); Wallace Medinova Private Limited (Director, 05 Feb 1997 to 17 Feb 2020); Shunyata Arts Private Limited (Director, 14 Mar 2001 to 30 Mar 2022); Wallace Estates Private Limited (Director, 30 Dec 1996 to 02 Feb 2020); and 2 more.
The current boards of Maria Emilia Dias Menezes's companies include Cesar Mauricio Jose De Menezes (Wallace Pharmaceuticals Private Limited), Pankaj Kumar (Wallace Pharmaceuticals Private Limited), Rajashekhar Rayanagoudar Basanagouda (Wallace Pharmaceuticals Private Limited), Rashmi Menezes (Wallace Pharmaceuticals Private Limited), Sandeep Inamdar (Wallace Pharmaceuticals Private Limited), Vinay Pinto (Wallace Pharmaceuticals Private Limited), among others.